[ad_1]
Over the years, 60 minutes has been responsible for reporting some of the greatest stories in the world. Many of the most memorable episodes involved interviews with world leaders, stories about endangered animals, famous celebrity profiles, and occasionally segments on promising developments in the business and science world. A week ago, 60 Minutes presented a very interesting report on how the authorities used genetic genealogy to solve the Golden State Killer case and how the authorities intend to continue using this new field to solve colder cases in the future.
On April 25, 2018, the Sacramento authorities announced that they had resolved the famous case of the Golden State Killer. The authorities were able to use a promising new technique called genetic genealogy to help identify the former 72-year-old police officer, Joseph DeAngelo, as the suspected killer.
Genetic Genealogy
Genetic genealogy is a blend of high-tech DNA analysis, high-speed computer technology, and family genealogy. The ultimate goal is to determine the level and type of genetic relationship between individuals.
In the case of the Golden State Killer, the DNA came into play because the killer had committed at least 12 murders, 50 rapes and many home thefts. Investigators were able to get DNA from the killer in one of the reported crime scenes. After many years of frustrating blind alleys, a cold case investigator submitted the DNA sample obtained to GEDmatch. GEDmatch is the largest public genealogy database in the world. After loading the sample, the authorities were able to generate a handful of cables that eventually led to the doors of Joseph DeAngelo.
In addition to the Golden State Killer case, the authorities used genetic genealogy to make arrests in at least 11 other cold cases. While science seems to be healthy, there is a legal question that has yet to be resolved. There is no doubt that the lawyers for the defendants will raise the question of privacy and if the use of databases, considered private, should be legal.
Opportunities for Crypto investors
While I have invested in stocks and cryptocurrencies for many years with varying degrees of success, I have never had the opportunity to invest at the start of a new frontier. Fortunately, the opportunity has arrived. Encrypgen (DNA) is a network of genomic blocks that offers customers and partners the best next generation blockchain security to protect, share and re-market genomic data. This creates a fair market for a person's DNA that can be stored private and sold (if a person wishes to do so).
In recent months, Encrypgen has drawn the attention of mainstream media due to their revolutionary technology and the fact that their tighter competition is still years away.
In August, Encrypgen released a beta version of its gene chain. The gene chain allows consumers to upload their genetic profile and researchers to purchase genetic data. Within the next 2 weeks, the company plans to release the full version of the Gene-Chain that will officially make them a new pioneer in the field of genomic blockchain safety.
With the DNA token hovering at around 5 cents, time is running out to accumulate at bargain prices. I expect the token to reach utility in the coming months, which will cause a rocket-like explosion in the symbolic price. You do not look back now, only forward, and I love what I see.
Featured image courtesy of Shutterstock.
